Nasdaq biol
BIOL- running earnings 8/10 LONG BIOL had a triple top in late July so this is a logical long target at 8,0, With earnings in less than two days, volumes above the mean in the past couple of days and a decent price-volume product trend coupled with a Price Monetum Oscillator without any signs of topping out in a momentum stall BIOL had a triple top in late July so this is a logical long target ...The company's shares jumped 32.6% to $3.46 in premarket trading. Tracon pharmaceuticals, inc.'s shares surged 116.9% after reporting better- than-expected sales. BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists ...
Did you know?
BIOL Sales Forecast. Next quarter’s sales forecast for BIOL is $14.75M with a range of $13.35M to $16.70M. The previous quarter’s sales results were $10.92M. BIOL beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 46.34% of the time in the same period.01 Mar, 2022, 16:15 ET. FOOTHILL RANCH, Calif., March 1, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced that its Board of Directors ...Biolase Inc NASDAQ 1.090 -0.020 -1.80% After Hours: 1.130 +0.04 +3.67% 19:32 11/30 EST OPEN 1.140 PREV CLOSE 1.110 HIGH 1.180 LOW 1.071 VOLUME 237.58K …
The firm earned $10.92 million during the quarter. BIOLASE has generated ($158.82) earnings per share over the last year ( ($158.82) diluted earnings per share). BIOLASE has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 26th, 2024 based off prior year's report dates.BIOLASE, Inc. (NASDAQ:BIOL) said its second-quarter revenues climbed 2.11% to $9.1 million. The company reported break-even results as opposed to the loss of 12 cents per share a year earlier. The ...28 Feb, 2019, 08:00 ET. IRVINE, Calif., Feb. 28, 2019 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, announced the appointment of Sinclair Dental Co. Ltd, the ...Nov 29, 2023 · What is BIOLASE's consensus rating and price target? According to the issued ratings of 2 analysts in the last year, the consensus rating for BIOLASE stock is Buy based on the current 2 buy ratings for BIOL. The average twelve-month price prediction for BIOLASE is $77.00 with a high price target of $150.00 and a low price target of $4.00. LAKE FOREST, Calif., March 17, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year ...
Jun 13, 2021 · Biolase Inc (NASDAQ:BIOL) is not the least popular stock in this group but hedge fund interest is still below average. Our overall hedge fund sentiment score for BIOL is 19.8. Stocks with higher ... LAKE FOREST, Calif., June 5, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, is taking the necessary steps to optimize operations to capitalize on the rising business momentum for its market-leading dental lasers.The Company believes its revenue-generating strategies and prudent … ….
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Nasdaq biol. Possible cause: Not clear nasdaq biol.
LAKE FOREST, Calif., Aug. 24, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to present at the Lake Street 6 th Annual Best Ideas Growth Conference being held September 14, 2022. John Beaver, President and Chief Executive Officer, and Jennifer Bright, Chief …100.03%. Get the latest BIOLASE Inc (BIOL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.BIOL After-Hours Quotes. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary ...
FOOTHILL RANCH, Calif., Jan. 26, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced unaudited preliminary revenue results for its fourth ...Biolase, Inc. Common Stock (BIOL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Biolase Inc (NASDAQ:BIOL) $1.165 -0.075 [-6.05%] Last update: 3:45PM (Delayed 15-Minutes) Get Real Time Here $1.17 0.0050 [0.43%] Profile News Analyst …
can you day trade with charles schwab Biolase (NASDAQ:BIOL) has filed to offering 125,000 unites, each consisting of:One Share of Series J Convertible Preferred Stock with a Liquidation Preference of $100.00 and One Warrant to... Investing.com; Aug 30, 2023 21:35Apr 28, 2022 · The Nasdaq Capital Market requires, among other things, that a listing a company's common stock maintain a minimum bid price of at least $1.00 per share. Information for BIOLASE Stockholders wsj contacttail etf The Nasdaq Capital Market requires, among other things, that a listing a company's common stock maintain a minimum bid price of at least $1.00 per share. Information for BIOLASE Stockholders quarter years worth money BIOLASE, Inc. (NASDAQ:NASDAQ:BIOL) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ETCompany ParticipantsTodd Kehrli - Investor Relations, EVC... kvyo stockhow do you short a currencybest daytrading platform Feb 4, 2021 · According to the recent notification letter, the staff of NASDAQ has determined that for the last ten consecutive business days, from January 21, 2021 to February 3, 2021, the closing bid price of ... psil etf The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange. thinkorswim vs streetsmart edgevirtual insurance companiesgates industrial Nov 8, 2023 · BIOL) stock’s latest price update. The stock price of Biolase Inc (NASDAQ: BIOL) has jumped by 6.01 compared to previous close of 1.58. Despite this, the company has seen a fall of -0.30% in its stock price over the last five trading days. Source: Kantar Media. Advertisement. Biolase Inc. analyst ratings, historical stock prices, earnings estimates & actuals. BIOL updated stock price target summary.